Your browser doesn't support javascript.
loading
Effectiveness of pembrolizumab in patients with urothelial carcinoma receiving proton pump inhibitors.
Fukuokaya, Wataru; Kimura, Takahiro; Komura, Kazumasa; Uchimoto, Taizo; Nishimura, Kazuki; Yanagisawa, Takafumi; Imai, Yu; Iwatani, Kosuke; Ito, Kagenori; Urabe, Fumihiko; Tsuzuki, Shunsuke; Kimura, Shoji; Terada, Naoki; Mukai, Shoichiro; Oyama, Yu; Abe, Hirokazu; Kamoto, Toshiyuki; Azuma, Haruhito; Miki, Jun; Egawa, Shin.
Afiliação
  • Fukuokaya W; Department of Urology, The Jikei University School of Medicine, Minato-ku, Tokyo, Japan.
  • Kimura T; Department of Urology, The Jikei University School of Medicine, Minato-ku, Tokyo, Japan. Electronic address: tkimura@jikei.ac.jp.
  • Komura K; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki, Osaka, Japan. Electronic address: kazumasa.komura@ompu.ac.jp.
  • Uchimoto T; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki, Osaka, Japan.
  • Nishimura K; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki, Osaka, Japan.
  • Yanagisawa T; Department of Urology, The Jikei University School of Medicine, Minato-ku, Tokyo, Japan.
  • Imai Y; Department of Urology, The Jikei University School of Medicine, Minato-ku, Tokyo, Japan.
  • Iwatani K; Department of Urology, The Jikei University School of Medicine, Minato-ku, Tokyo, Japan.
  • Ito K; Department of Urology, The Jikei University School of Medicine, Minato-ku, Tokyo, Japan.
  • Urabe F; Department of Urology, The Jikei University School of Medicine, Minato-ku, Tokyo, Japan.
  • Tsuzuki S; Department of Urology, The Jikei University School of Medicine, Minato-ku, Tokyo, Japan.
  • Kimura S; Department of Urology, The Jikei University School of Medicine, Minato-ku, Tokyo, Japan.
  • Terada N; Department of Urology, Faculty of Medicine, University of Miyazaki, Miyazaki-city, Miyazaki, Japan.
  • Mukai S; Department of Urology, Faculty of Medicine, University of Miyazaki, Miyazaki-city, Miyazaki, Japan.
  • Oyama Y; Department of Medical Oncology, Kameda Medical Center, Kamogawa City, Chiba, Japan.
  • Abe H; Department of Urology, Kameda Medical Center, Kamogawa City, Chiba, Japan.
  • Kamoto T; Department of Urology, Faculty of Medicine, University of Miyazaki, Miyazaki-city, Miyazaki, Japan.
  • Azuma H; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki, Osaka, Japan.
  • Miki J; Department of Urology, The Jikei University School of Medicine, Minato-ku, Tokyo, Japan.
  • Egawa S; Department of Urology, The Jikei University School of Medicine, Minato-ku, Tokyo, Japan.
Urol Oncol ; 40(7): 346.e1-346.e8, 2022 07.
Article em En | MEDLINE | ID: mdl-35346571
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Carcinoma de Células de Transição Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Carcinoma de Células de Transição Idioma: En Ano de publicação: 2022 Tipo de documento: Article